The Claim
Melatonin administration is associated with reduced platelet aggregation and lower serum catecholamine levels in patients with cardiovascular conditions, which are proposed to contribute to decreased thrombotic risk and reduced cardiac workload as part of its cytoprotective effects in ischemic and hypertensive states.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking melatonin seems to help blood flow better and lower stress hormones in people with heart problems. This might make the heart work less hard and lower the chance of dangerous blood clots forming.
See the scientific wording
Melatonin administration is associated with reduced platelet aggregation and lower serum catecholamine levels in patients with cardiovascular conditions. These hemodynamic and hematological changes are proposed to contribute to decreased thrombotic risk and reduced cardiac workload, forming part of melatonin's broader cytoprotective profile in ischemic and hypertensive states.
What the research says
1 studyStudy: Chronobiotic and cytoprotective activity of melatonin in the cardiovascular system. Doses matter
The study confirms that taking melatonin helps lower stress hormones and prevents blood clots in people with heart problems, which protects the heart.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.